Follicular dendritic cells in vitro are not susceptible to infection by HIV-1. 1996

R Tsunoda, and K Hashimoto, and M Baba, and S Shigeta, and N Sugai
Department of Histology and Microbiology, Fukushima Medical College, Japan.

OBJECTIVE To investigate whether follicular dendritic cells (FDC) are target cells for HIV-1 infection. METHODS Based on the principle that if FDC are true target cells, HIV-1 particles will bind to the surface of FDC and then invade their cytoplasm and nuclei. METHODS Freshly isolated tonsilar FDC were exposed to two strains (HE and JR-FL) of HIV-1 and cultured. They were then examined for HIV-1 replication, using p24 antigen-capture enzyme-linked immunosorbent assay, immunolabelling, and polymerase chain reaction (PCR) amplification. We used FDC clusters as the FDC source, since the culture system for FDC clusters has various advantages over other methods for the successful long-term culture of FDC. RESULTS After 2 h incubation, particles of both HIV-1 strains bound to the surfaces of FDC, as well as to CD4+ T cells, although FDC do not have CD4 receptors. The FDC gradually released the particles into the culture supernatant. More HIV-1 particles were bound to fresh FDC than to dedifferentiated FDC or to control fibroblasts. However, HIV-1 particles bound to the FDC did not seem to enter the cells. We found no evidence of HIV-1 proviral DNA synthesis in FDC. CONCLUSIONS Our results suggest that FDC are not readily infected with HIV-1 in situ, although we found that FDC in vitro were not infected by HIV-1.

UI MeSH Term Description Entries
D007118 Immunoassay A technique using antibodies for identifying or quantifying a substance. Usually the substance being studied serves as antigen both in antibody production and in measurement of antibody by the test substance. Immunochromatographic Assay,Assay, Immunochromatographic,Assays, Immunochromatographic,Immunoassays,Immunochromatographic Assays
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003713 Dendritic Cells Specialized cells of the hematopoietic system that have branch-like extensions. They are found throughout the lymphatic system, and in non-lymphoid tissues such as SKIN and the epithelia of the intestinal, respiratory, and reproductive tracts. They trap and process ANTIGENS, and present them to T-CELLS, thereby stimulating CELL-MEDIATED IMMUNITY. They are different from the non-hematopoietic FOLLICULAR DENDRITIC CELLS, which have a similar morphology and immune system function, but with respect to humoral immunity (ANTIBODY PRODUCTION). Dendritic Cells, Interdigitating,Interdigitating Cells,Plasmacytoid Dendritic Cells,Veiled Cells,Dendritic Cells, Interstitial,Dendritic Cells, Plasmacytoid,Interdigitating Dendritic Cells,Interstitial Dendritic Cells,Cell, Dendritic,Cell, Interdigitating,Cell, Interdigitating Dendritic,Cell, Interstitial Dendritic,Cell, Plasmacytoid Dendritic,Cell, Veiled,Cells, Dendritic,Cells, Interdigitating,Cells, Interdigitating Dendritic,Cells, Interstitial Dendritic,Cells, Plasmacytoid Dendritic,Cells, Veiled,Dendritic Cell,Dendritic Cell, Interdigitating,Dendritic Cell, Interstitial,Dendritic Cell, Plasmacytoid,Interdigitating Cell,Interdigitating Dendritic Cell,Interstitial Dendritic Cell,Plasmacytoid Dendritic Cell,Veiled Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014066 Palatine Tonsil A round-to-oval mass of lymphoid tissue embedded in the lateral wall of the PHARYNX. There is one on each side of the oropharynx in the fauces between the anterior and posterior pillars of the SOFT PALATE. Tonsil,Tonsil, Palatine,Palatine Tonsils,Tonsils,Tonsils, Palatine
D015488 HIV Antigens Antigens associated with specific proteins of the human adult T-cell immunodeficiency virus (HIV); also called HTLV-III-associated and lymphadenopathy-associated virus (LAV) antigens. AIDS Antigens,HIV-Associated Antigens,HTLV-III Antigens,HTLV-III-LAV Antigens,LAV Antigens,Lymphadenopathy-Associated Antigens,T-Lymphotropic Virus Type III Antigens, Human,HIV Associated Antigens,HTLV III Antigens,HTLV III LAV Antigens,Lymphadenopathy Associated Antigens,T Lymphotropic Virus Type III Antigens, Human,Antigens, AIDS,Antigens, HIV,Antigens, HIV Associated,Antigens, HIV-Associated,Antigens, HTLV III,Antigens, HTLV-III,Antigens, HTLV-III-LAV,Antigens, LAV,Antigens, Lymphadenopathy Associated,Antigens, Lymphadenopathy-Associated,Associated Antigens, HIV,Associated Antigens, Lymphadenopathy,III Antigens, HTLV
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human

Related Publications

R Tsunoda, and K Hashimoto, and M Baba, and S Shigeta, and N Sugai
December 2007, Journal of virology,
R Tsunoda, and K Hashimoto, and M Baba, and S Shigeta, and N Sugai
January 1994, Advances in experimental medicine and biology,
R Tsunoda, and K Hashimoto, and M Baba, and S Shigeta, and N Sugai
January 1995, Bollettino della Societa italiana di biologia sperimentale,
R Tsunoda, and K Hashimoto, and M Baba, and S Shigeta, and N Sugai
January 2008, AIDS research and therapy,
R Tsunoda, and K Hashimoto, and M Baba, and S Shigeta, and N Sugai
September 1994, Journal of leukocyte biology,
R Tsunoda, and K Hashimoto, and M Baba, and S Shigeta, and N Sugai
September 2003, Virology,
R Tsunoda, and K Hashimoto, and M Baba, and S Shigeta, and N Sugai
September 2000, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses,
R Tsunoda, and K Hashimoto, and M Baba, and S Shigeta, and N Sugai
January 1993, Advances in experimental medicine and biology,
R Tsunoda, and K Hashimoto, and M Baba, and S Shigeta, and N Sugai
November 2017, AIDS research and human retroviruses,
Copied contents to your clipboard!